Karmanos Cancer Institute First in the World to use FDA-approved Radiofrequency Electromagnetic Device to Treat Liver Cancer
On Dec. 18, 2024, the Barbara Ann Karmanos Cancer Institute announced that the new TheraBionic P1 device, an…
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Oncology | Radiology | Therapeutics
Study revealed how deadly brain tumor evades treatment; identifies potential new treatment strategy
On Nov. 21, 2024, a study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why…
NIH-funded scientists uncover clues to precancer and tumor biology
On Oct. 30, 2024, ten studies from the Human Tumor Atlas Network (HTAN), a National Institutes of Health…
Biotechnology | Diagnostics | Disease | NIH | Oncology | Radiology | Therapeutics | Women's Health
NCI’s Cancer Trends Progress Report announced 2023 Incidence and Mortality Data
On Sep. 3, 2024, the National Cancer Institute (NCI) announced that the latest Cancer Trends Progress Report included…
Artificial Intelligence | Biotechnology | CRISPR | Genomics | Life Science History | Medicine | NIH | Non-Profit Research | Therapeutics | Vaccine
Biden announced $150 million in research grants as part of his ‘moonshot’ push to fight cancer
On Aug. 13, 2024, President Joe Biden announced $150 million in awards from the Advanced Research Projects Agency…
largest population-based study to date supported the survival benefits of immunotherapy for people with metastatic non-small cell lung cancer
On Jul. 29, 2024, a team led by the Barbara Ann Karmanos Cancer Institute and the Wayne State…
DNA from Ancient Viruses Helps Many Cancers Grow
On Jul. 17, 2024, the National Cancer Institute (NCI) announced that a study, funded in part by the…
Biotechnology | Diagnostics | Disease | Genomics | NIH | Oncology | Therapeutics
Analysis identified 50 new genomic regions associated with kidney cancer risk
On Apr. 26, 2024, an international team of researchers led by the National Cancer Institute (NCI) released an…
NIH launched research network to evaluate emerging cancer screening technologies
On Feb. 21, 2024, the National Institutes of Health (NIH) announced it had launched a clinical trials network…
W. Kimryn Rathmell, M.D., Ph.D., began work as 17th director of the National Cancer Institute
On Dec. 18, 2023, W. Kimryn Rathmell, M.D., Ph.D., began work as the 17th director of the National…
Purdue nameed new pediatric cancer research center for the late Tyler Trent
On Oct. 14, 2023, Purdue University ensured that the memory of the former graduate and devoted Boilermaker football…
The Markey Cancer Center became an NCI-designated Comprehensive Cancer Center
On Sept. 6, 2023, the Markey Cancer Center (MCC) became Kentucky’s first and only National Cancer Institute (NCI)-Designated…
U.S. Department of Health and Human Services released National Cancer Plan
On Apr. 3, 2023, the U.S. Department of Health and Human Services (HHS) released a National Cancer Plan,…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics | Women's Health
FDA updated mammography regulations to require reporting of breast density information and facility oversight
On Mar. 9, 2023, the U.S. Food and Drug Administration (FDA) announced that it had published updates to…
Purdue Center for Cancer Research renamed Purdue Institute for Cancer Research
On Jan. 6, 2023, the Purdue Center for Cancer Research announced it was changing its name to the…
Karmanos completed $48 million expansion at Farmington Hills cancer center
On Oct. 26, 2022, the Barbara Ann Karmanos Cancer Institute announced it had completed an over 50,000-square-foot expansion…
Monica Bertagnolli began work as 16th director of the National Cancer Institute
On Oct. 3, 2022, Monica M. Bertagnolli, M.D., started as the 16th director of the National Cancer Institute….
Wake Forest CCSG cut from 5 years to 3 as center changes leadership, administrative structure
May 27, 2022, the National Cancer Institute (NCI) truncated the just-renewed five-year Cancer Center Support Grant held by…
NIH launched program to offer molecular characterization of childhood cancers
On Mar. 21, 2022, in support of the Cancer Moonshot? goal of fostering data sharing in cancer research,…
Researchers generated the first complete, gapless sequence of a human genome
On Mar. 21, 2022, in support of the Cancer Moonshot goal of fostering data sharing in cancer research,…
The University of Virginia Cancer Center Received NCI Comprehensive Designation
On Feb. 1, 2022, University of Virginia Cancer Center announced it had been awarded a Comprehensive Cancer Center…
Artificial Intelligence | Biotechnology | CRISPR | Genomics | Life Science History | Medicine | NIH | Non-Profit Research | Therapeutics | Vaccine
Cancer MoonShot program reignited
On Feb. 2, 2022, President Biden announced a reignition of the Cancer Moonshot, that highlighted new goals: to…
Biotechnology | NIH | Oncology | Therapeutics
the Fred & Pamela Buffett Cancer Center received NCI designated cancer center renewal
On Oct. 4, 2021, the Fred & Pamela Buffett Cancer Center announced it had successfully renewed its National…
Asthma drug budesonide shortened recovery time in non-hospitalised patients with COVID-19
On Apr. 12, 2021, Oxford University reported that early treatment with inhaled budesonide shortened recovery time by a…
Antiviral drug Favipiravir investigated as a possible COVID-19 treatment for at-home recovery in PRINCIPLE trial
On Apr. 8, 2021, Oxford University announced that favipiravir was to be investigated in the UK as part…
PRINCIPLE found antibiotics azithromycin and doxycycline not generally effective treatments for COVID-19
On Jan. 25, 2021, scientists at the University of Oxford reported that after reviewing interim analyses of both…
Patients in cancer remission at high risk for severe COVID-19 illness
On Jan. 21, 2021, Penn Medicine reported that patients with inactive cancer and not currently undergoing treatments also…
NIH launched the Serological Sciences Network for COVID-19, announced grant and contract awardees
On Oct. 8, 2020, the National Cancer Institute (NCI) launched the Serological Sciences Network for COVID-19 (SeroNet), an…
Biotechnology | COVID-19 | Disease | Medicine | NIH | Therapeutics
La Jolla Institute for Immunology awarded $1.4 million to study COVID-19 in Latino Americans
On Oct. 8, 2020, the La Jolla Institute for Immunology (LJI) announced it had been granted $1.4 million…
NCI and Cancer Research UK launched Cancer Grand Challenges partnership to support bold new ideas for cancer research
On Aug. 27, 2020, the National Cancer Institute (NCI) announced a partnership with Cancer Research UK to fund…